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Investigations on the distribution of the blood group specific  substances A and B 
within  the  human  body revealed  the  fact that  the  entire  body has group specific 
stigmata  (1-3).  There  is  an  interesting  quantitative  difference  in  the  content of 
various  organs  in  regard  to  group  specific  properties  (4-6).  Saliva, gastric juice, 
and amnlotic fluid contain group  specific  substances in high  concentration as dem- 
onstrated  by  Putkonen  (7)  and  Hartmann  (8).  The  secretion  of  group  specific 
substances is a constitutional property which is inherited; the gene of secretion being 
dominant over the gene of non-secretion (9).  Roughly about six out of seven human 
beings  are  secretors.  At  the  present  time  it  appears  that  two  different  chemical 
substances  carry  group  specific  characteristics;  a  water-soluble  substance,  carbo- 
hydrate-like  in  nature  and  an  alcohol-soluble  substance,  lipoid-like  in  nature  (5). 
Only the carbohydrate form is found in the secretions such as saliva. 
Results  of studies  on  the  distribution  of the Rh factor within  the  human body 
seemed to limit the Rh factor to blood cells only.  However, Boorman and ]3odd (10) 
report the occurrence of the Rh factor in tissue cells although this factor proved to be 
insoluble in water.  According to the same authors, saliva specimens from Rh-positive 
individuals in a  dilution of 1:2 exert a weak inhibitory effect on Rh agglutination in 
about one-half of the cases studied.  Yet they feel that the Rh substances are almost 
entirely absent from body fluids.  On the other hand, Levine (11) did not find the Rh 
factor in saliva.  Wiener and Forer (12),  apparently being convinced of the absence 
of Rh substance in saliva, recommend the use of saliva for the neutralization of the 
isoagglutinins  anti-A  and  anti-B  in  anti-Rh  serum. 
Previous  investigations  (13-15)  have  shown  that  the  decidua  contains the 
blood group specific factor of the mother, and the amnion contains that of the 
baby.  The blood group of the  child  and not that  of the mother determined 
the  blood  group  specific  substances  occurring  in  amniotic  fluid  (7).  In  the 
investigations to be reported the amniotic fluid has been chosen as the secretion 
to be  studied  because  of its  possible  bearing  on the pathogenesis  of erythro- 
blastosis  and  because  of  the  relative  ease  with  which  it  is  obtainable. 
Materials 
Anti-Rh  Sera.--The greatest  difficulty in investigating  problems in connection with the 
Rh factor is the lack of suitable and sufficiently large amounts of anti-Rh serum.  We were 
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fortunate in having at our disposal a potent anti-Rh serum (Kru) obtained from a patient of 
the blood group O who had received multiple transfusions of group O blood.  The last trans- 
fusion had resulted in a severe hemolytic transfusion reaction whose cause could be traced to 
the formation of Rh antibodies in the patient who was found to be Rh-negative.  The agglu- 
tination of Rh-positive cells with this serum was stronger at room temperature or in the ice 
box than at body temperature.  In this respect our serum differs from the vast majority of Rh 
antisera obtained from patients with erythroblastotic children.  This type of serum has been 
observed previously (16,  17).  The serum (Kru) was of the 87 per cent variety (anti-Rh~). 
In addition to that, smaller amounts of anti-Rh sera of the 87 per cent variety (anti-Rh~, the 
70 per cent (anti-Rh'), and the 30 per cent (anti-Rh') varieties were at our disposal.  1 
Amniotic Fluid.--Care  was taken to avoid as far as possible contamination of the amniotic 
fluids with maternal blood; however, in a  few instances amniotic fluids containing traces of 
blood were included in our series.  Frankly bloody amniotic fluids were excluded from this 
investigation.  The amounts obtained varied  from  10  ml.  to  1000  ml.  The  majority of 
fluids were collected by artificial rupturing of the fetal membranes at the time of delivery, 
although some were obtained from Caesarean sections or from cases with spontaneous rupture 
of their membranes.  2  The amniotic fluids were  spun  down  as  soon  as  received,  and  the 
supernatants stored at  --20°C. 
A few milliliters of placental blood were collected in a Wassermann tube and examined for 
the blood group  and the Rh factor.  In  some instances in which no placental blood was 
obtainable, a  few drops of blood from the baby's heel were collected in citrate solution.  In 
many instances the mother's blood was  examined also. 
Methods 
The determinations of the blood group and the Rh type of the maternal bloods and placental 
bloods were carried out in test tubes using potent test sera for that purpose.  Our 87 per cent 
anti-Rh serum (Kru) was used as routine for the determination of the Rh factor.  As far as 
available anti-Rh' and anti-Rh', as well as other anti~Rh sera, were used for the determi- 
nations of the subtypes of the Rh factor. 
Inhibition of agglutination was used as the basic experimental test in the investigations to 
be reported.  The underlying principle consists in the neutralization of antibodies by cor- 
responding antigenic substances without leading to visible precipitXtion.  This test was used 
for the determination of the blood group specific substances A and B and the Rh substances 
occurring in amniotic fluid.  In both instances attention had to be paid to the optimal quanti- 
tative conditions requiring frequent preliminary fitrations. 
EXPERIMENTAL 
The first experiment to be reported deals with the principal issue of whether 
or not Rh  substances are secreted into the amniotic fluid.  Apparently  the Rh 
factors  are  present  even  in  blood  cells  in  a  much  lower  concentration  than 
the blood  group  specific substances A  and B  (18).  Obviously only relatively 
small amounts,  if  any  at  all,  could  be  expected  in  body  fluids. 
A  typical  experiment  done  in  order  to  find  out  the possible  content  of  Rh 
1 We are indebted to Dr. L. Diamond, Dr. P. Levine, and to Dr. A. S. Wiener for having 
made  these sera available to  us. 
2We  acknowledge  with  thanks the  cooperation  of  the  obstetrical  departments of  The 
Buffalo  General Hospital,  the  Children's Hospital,  and  the  Millard  Fillmore Hospital  of 
Buffalo, New York, and the Brooks Memorial Hospital of Dunkirk, New York, for supplying 
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substance in amniotic fluid is recorded in Table I.  The experiment itself was 
carried out in the following way:-- 
Decreasing amounts, volume 0.05 cc., of two amniotic fluids (A) originating from an Rh- 
positive baby; (B) originating from an Rh-negative baby, were mixed with 0.05 cc. of 1:4 
diluted anti-Rh serum (Kru, 87 per cent variety).  Mter being kept for 2 hours in the ice box 
(4  ° C.) and 10 minutes at room temperature, 0.05 cc. of a 3 per cent suspension of Rhl cells 
belonging to blood group O was added.  The mixtures were thoroughly shaken and kept for 1 
hour at room temperature.  The tubes were then spun down in a centrifuge at medium speed 
for  1 minute.  The resulting  agglutinations,  read  macroscopically are  shown in Table I. 
The amniotic fluid obtained from an Rh-positive baby definitely inhibits the 
agglutination of  Rhl  cells.  The  amniotic fluid  from  an  Rh-negative baby 
TABLE I 
Agglutination  of Rhl Cells by Anti-Rh Serum (87 Per Cent) after  Treatment of the Latter with 
A mniotic Fluids 
Liquor amnii  supcrnatants 
(1) Undiluted 
(2) 1:2 
(3) 1:~ 
(4) 1:8 
(5) 1:16 
(6) 1:32 
(7) 1:64 
(8)  0 
A  B 
~niofic fired from an  ~Mo~c fl~dfrom 
~-~sitivc  baby  Rh-negative baby 
--  ++ 
--  +++ 
--  +++ 
±  +++ 
+  +++ 
++  +++ 
++  +++ 
+++  +++. 
--  =  no agglutination. 
-4- =  faint agglutination. 
+  =  slight agglutination. 
++  ---- marked agglutination. 
+++  -= strong agglutination. 
+ + + +  -= very strong agglutination. 
fails to do so.  The experiment shows, therefore, that Rh substances do occur 
in amniotic fluid3 
The scarcity of Rh antisera prevented us from doing comparative studies on 
a larger scale.  However, it was felt that the degree of inhibition  as well as the 
specificity of  the  reaction was  increased by keeping the  antiserum-amniotic 
fluid mixtures in the ice box instead of at body temperature during the first 
phase of the experiment. 
Our  anti-Rh serum  (Kru,  87  per  cent variety)  agglutinating Rh-positive 
cells stronger at  lower  temperatures than at  body  temperature is  obviously 
suitable for  experiments of  the  type just described.  Other  Rh  antisera ob- 
tained  from  Rh-negative mothers  who  had  given birth  to  erythroblastotic 
SThe inhibition  of agglutination experiments described here serve for the identification of 
the Rh substances proper and should not be confused with the "blocking antibody" recently 
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children  were  also  studied  regarding  their  usefulness  in  demonstrating  the 
occurrence  of Rh  substances  in  amniotic fluids. 
In the following experiment two such sera were compared, one an anti-Rh' 
serum  (70 per cent variety), and  the  second,  a  different anti-Rh~ serum  (87 
per cent variety, DiY,  obtained from  Dr.  Diamond).  The  experiment itself 
was  carried  out  as follows:-- 
Decreasing amounts of the same amniotic fluids used in Experiment 1, namely, one from 
an Rh-positive baby, and one from an Rh-negative baby, volume 0.05 cc., were mixed with, 
(I) 1:4 diluted anti-Rh' serum (70 per cent variety); (II) 1:2 diluted anti-Rh~ serum  (DiY, 
87 per cent variety).  Mter incubation for 2 hours in the ice box (4  ° C.), 0.05 cc. of a 3 per cent 
suspension of Rhl cells belonging to blood group O was added.  The tubes were shaken well 
and kept for I hour in the water bath at 37 ° C.  They were then spun down in a centrifuge at 
medium speed  for  1 minute and read macroscopically  for agglutination.  The results are 
given  in Table II. 
TABLE II 
Agglutination  of Rhl Cells by Auti~-R.h Sera after Treatment of the Latter with Amniotiv Fluids 
Liquor anmii 
supernatants 
(1)  Undiluted 
(2)  1:3 
(3)  1:9 
(4)  1:27 
(5)  0 
I 
Anti-Rh' serum (70 per cent) 
Amniotic fluid from 
Rh-positive baby 
+ 
+ 
++ 
+++ 
Amniotic fluid from 
Rh-negativc baby 
+++ 
+++ 
+++ 
+++ 
+++ 
II 
Anti-Rl~ Serum (DiY, 87 per cent) 
Amniotic fluid from 
Rh-positive baby 
+ 
+ 
++ 
+++ 
+++ 
Amuiotic fluid  from 
Rh-negative baby 
++ 
+++ 
+++ 
+++ 
+++ 
Agglutination of Rhl  ceils is inhibited  to  a  certain extent  at  least by the 
Rh-positive amniotic fluid.  The specificity of the inhibition is proved by the 
failure of  the  Rh-negative  fluid to  inhibit the agglutination of  the  Rhl  ceils 
under  the  same  conditions.  However,  the  anti-Rh  serum  used  in  the  first 
part  of  the  experiment  (anti-Rh  t)  seems  to  be  better  suited for  the  type  of 
experiments described than the second serum  (anti-Rt~, DiY).  In the  latter 
case,  the degree of inhibition is rather limited and would not be sufficient to 
draw  any  definite  conclusions.  It  can  easily be  understood  therefore,  that 
investigators may fail to recognize the presence of Rh substances in amniotic 
fluid if such an anti-Rh serum is used.  According to our experience, there is a 
considerable individual difference as to the usefulness of various anti-Rh sera 
for the  demonstration  of the  Rh  substances  in amniotic fluid. 
The importance of quantitative considerations in regard to the demonstration 
of Rh substances in amniotic fluid, is illustrated by the following experiment :-- 
Decreasing  amounts of (A) an R_h-positive amniotic fluid,  (B)  an Rh-negative anmiofic 
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with 0.05 cc. of the anfi-Rh serum Kru diluted, (I) 1:4; (I_I) 1:8; and (III) 1 : 16.  The mix- 
tures were incubated for 2 hours in the ice box and kept for 10 minutes at room temperature 
whereupon 0.05 cc. of a 3 per cent suspension of Rhl cells belon#ng to the blood group O was 
TABLE III 
Agglutinat¢on of Rhl Cells by Different Dilutions  of Anti-Rk Serum  after Treatment of the 
Latter witk Amniotie Fluids 
A  B 
Liquor ~rnnll supernatants  Amniotic fluid from an  Amniotic fluid from an 
Rh-positive baby  Rh-negative baby 
Part I 
Agglutination  of Rh, Cells by 1 :___4 Diltued Anti-Rh Serum 
(1)  Undiluted 
(2)  1:2 
(3)  1:4 
(4)  l:S 
(5)  1:16 
(6)  1:32 
(7)  0 
++ 
+++ 
+++ 
+++ 
+++ 
+++ 
++++ 
+++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
Part II 
Agglutination of Rh, Cdls by 1:8 Diluted Anti-Rh Serum 
(1)  Undiluted 
(2)  1:2 
(3)  1:4 
(4)  1:8 
(5)  1:16 
(6)  1:32 
(7)  0 
4- 
4- 
+ 
+ 
++ 
++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
Part Ill 
Agglutination  of Rhl  Cells by 1:16 Diluted Anti-Rh Serum 
(1)  Undiluted 
(2)  1:2 
(3)  1:4 
(4)  1:8 
(5)  1:16 
(6)  1:32 
(7)  0 
± 
-4- 
+ 
++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
added.  The tubes were shaken thoroughly, kept for 1 hour at room temperature, and spun 
down.  The resulting agglutination is shown in Table III. 
This experiment points to the importance of the Rh antiserum dilution used. 
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the  Rh  substance  in the  Rh-positive  amniotic fluid.  In contrast,  the  same 
antiserum  when  diluted  1:16  is  definitely  inhibited  by  this  amniotic  fluid. 
The specificity of the inhibition is demonstrated  by the failure  of the Rh-neg- 
ative  amniotic  fluid  to  show  a  similar  degree  of  inhibitory  potency.  We, 
therefore,  chose for our experiments  antiserum  dilutions producing a  3+  ag- 
glutination  in the  control tube  rather  than  a  4+  agglutination  which is fre- 
quently  too  strong  to  give  clear  cut  results.  On  the  other  hand,  definite 
agglutination  has  to be  achieved  in  order  to  avoid  mistaken  interpretations 
of experimental findings.  For this reason preliminary titrations with mixtures 
of decreasing amounts of the P,h antisera and the Rh-positive ceils to be used 
in the  main experiment  were set  up in order  to find  the  optimal  conditions. 
The examination  of amniotic fluids for the presence or absence of Rh sub- 
stance is complicated by the existence  of different subtypes of the Rh factor. 
Consequently,  all  experiments  were  set  up  with  both  Rhl  and  Rh,  cells  as 
routine.  In addition, Rh0 cells were used whenever the circumstances seemed 
tO warrant  them.  To our surprise,  the majority of amniotic fluids examined 
contained Rh2 as well as Rhl substances.  However, there was a small number 
of amniotic fluids which seemed  to contain  either  the  Rh~ or the  Rh2  factor 
alone  as  shown  in  the  following  experiment:-- 
Decreasing amounts of amniotic fluid, volume 0.05 cc., were mixed with 0.05 cc. of our 
anti-Rh serum (Kru, 87 per cent variety) and kept for 2 hours in the ice box.  Mter standing 
for 10 minutes at room temperature,  0.05 cc. of a 3 per cent suspension of Rh-positive cells 
was added.  The mixtures were allowed to remain for 1 hour at room temperature  and then 
spun down.  The experiment was carried out in three parts.  In Part I, Rhl group O cells, 
in Part II, Rh2 group B cells, and in Part III  Rh0 group O cells were added.  The anti-Rh 
serum was neutralized by the addition of the isolated blood group specific substances A and B 
(Lilly) (20) and used in final dilutions ranging from 1:4 to 1:6.  The respective dilution was 
determined by preliminary  agglutination  tests with the test cells employed.  Ten amuiotic 
fluids were examined in this experiment.  The first eight originated f~om Rh-positive babies, 
the ninth and tenth from Rh-negative ones.  The results are recorded in Table IV. 
The  following  facts  manifest  themselves  from  the  experiment  shown  in 
Table  IV:  (1)  The first  two  amniotic fluids,  (a)  and  (b),  inhibit  the aggluti- 
nation of Rhl  cells but not of Rh2  cells.  (2)  Amniotic fluids  (c)  and  (d)  in- 
hibit  the  agglutination  of Rh2 cells but there  is no  inhibition  or very  little 
inhibition  of agglutination  of Rhl cells.  (3)  Amniotic  fluids  (e)  and  (f) in- 
hibit  both Rhl and  Rh2 cells.  (4)  The  Rh-negative  fluids  (i)  and  (k)  fail  to 
show  any  inhibitory  substances. 
None of the fluids inhibits the agglutination of Rh0 cells to any considerable 
extent.  It should be mentioned,  however,  that  our series  of amniotic fluids 
came from white persons only and it is known that the Rh0 type occurs very 
rarely  (2.5  per  cent)  in  the  white  population  (21).  Besides,  the  antiserum 
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TABLE IV 
Agglutination of Rh-Positive Human Red Blood Cells by Anti-Rh Serum after Treatment of the 
Latter with Amniotic Fluids 
Liquor amnii 
supernatants 
Amnietic fluids from Rh  + babies 
(No. 
Amuiotic fluids 
from Rh-  babies 
(No,  iO~"  115) 
Part I 
Agglutination of Human Red Blood Cells of the Rhl Type by Anti-Rk 
of the Latter with Amnioti~ Fluids 
Serum after Treatment 
(1)  Undiluted 
(2)  1:2 
(3)  1:4 
(4)  1:8 
(5)  1:16 
(6)  1:32 
(7)  o 
m 
± 
+ 
+++++ 
[+++ 
'+++ 
++  ++ 
++1++ 
+++1  ++ 
+++1+++  +++l+++ 
+++  +++ 
+++  +++ 
-4- 
+ 
+++++ 
+++ 
-4- 
++++jr 
+++ 
++ 
++ 
F-+q 
F+-~ 
F-+q 
F+q 
++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
Part II 
Agglutination of Human Red Blood Cells of the Rh, Type by Anti-Rk 
of the Latter with Amniotic Fluids 
Serum after Treatment 
(1)  Undiluted  q-q-+ 
(2)  1:2  +++ 
(3)  1:4  +++ 
(4)  1:8  q-q-+ 
(5)  1:16  +++ 
(6)  1:32  i  x 
(7)  0  +++ 
++ 
++ 
b+q 
b+q 
k+-{ 
b+q 
+++  +++ 
-  --t-- 
-'I-++++  +++ 
++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
1++  +++  +++ 
++  +++  +++ 
i+++  +++  +++ 
+++  +++  +++ 
i+++  +++  +++ 
+++  +++  +++ 
+++  +++  +++ 
Part III 
Agglutination of Human Red Blood Cells of the Rho Type by Anti-Rh 
of the Latter with Amniotlc Fluids 
Serum after Treatment 
i 
(1)  Undiluted  ]+q-+ 
(2)  1:2  +++ 
(3)  1:4  +++ 
(4)  1:8  +++ 
(S)  1:16  +++ 
(6)  1:32  +++ 
(7)  0  +++ 
+++1  +  +++  +++ 
+++  +++ 
+++1+++ 
+++1+++ 
+++l+++ 
+++i+++ 
++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+-b+ 
+ 
++ 
+++ 
+++ 
+++ 
+++ 
+-b+ 
++  +++  +++]+++ 
+++  +++  ....  +++ 
+++  +++  ....  +++ 
-t-++ +-b+ +++l+++ 
+++  +++  +++!+++ 
+++  +++  +++~+++ 
+++  +++  +++l+++ 
+++ 
+++ 
+++ 
+++ 
-b-b+ 
+++ 
+++ 
x, tube missing. 
It is interesting  to note that two fluids,  (g) and  (h), do not contain any de- 
monstrable Rh substances in spite of the fact that the respective babies were 
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are derived from the baby and not from tbe mother, we are dealing here with 
two  cases  of  non-secret0rs. 
The  question  arose,  therefore,  whether  the  Rh  substances found  in  the 
amniotic fluid came from the baby or from the mother.  As mentioned before, 
the blood group specific substances found in the amniotic fluid correspond to 
the  baby's blood group and not to  the  mother's  (7).  In order  to  elucidate 
the origin of the Rh substances in the amniotic fluid, the relationship between 
TABLE V 
Occurrence of Rh Substances in A mniotic Fluid in Rdationship 
to the Rk Type  of  Mother  and Baby 
Case No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
Mother's blood 
Blood group  Rh type 
A  Rh- 
O  Rh  + 
O  Rh  + 
A  Rh- 
AB  Rh- 
O  Rh  + 
O  Rh  + 
O  Rh  + 
O  Rh  + 
O  Rh  + 
A  Rh  + 
A  Rh- 
O  Rh  + 
A  Rh  + 
AB  Rh  + 
A  Rh  + 
B  Rh  + 
O  Rh  + 
A  Rh  + 
AB  Rh- 
Baby's blood 
Blood group  Rh type 
A  Rh  + 
0  Rh  + 
A  Rh  + 
A  Rh  + 
AB  Rh  + 
A  Rh  + 
A  Rh  + 
A  Rh  + 
0  Rh  + 
O  Rh  + 
O  Rh- 
A  Rh  + 
0  Rh- 
A  Rh  + 
AB  Rh  + 
0  Rh  + 
B  Rh  + 
0  Rh  + 
A  Rh  + 
A  Rh  + 
Rh substances  in 
amuiotic fluid 
Positive 
Positive 
Positive 
Positive 
Negative 
Negative 
Positive 
Positive 
Positive 
Positive 
Negative 
Positive 
Negative 
Positive 
Negative 
Positive 
Positive 
Positive 
Positive 
Positive 
the occurrence of Rh substances on the one hand and the Rh types of mother 
and baby on the other hand was examined.  The findings in twenty more or 
less consecutive cases are recorded in Table V. 
There are five instances (Nos.  1, 4, 5,  12,  and  20)  of Rh-negative mothers 
with Rh-positive babies.  In four cases  (Nos.  1, 4,  12,  and 20)  the  amniotic 
fluids contained Rh substances.  Two examples  (Nos. 11  and 13)  of  Rh-pos- 
itive mothers with  Rh-negative babies are  given.  No  Rh  substances were 
found in the respective amniotic fluids.  Consequently, the Rh content of the 
amniotic fluid is determined by the baby's Rh type and not that of the mother. 
In two  instances (Nos.  6  and  15)  no  Rh  substances were  present in the 
amniotic fluids in spite of the fact that both mother and baby were found to be ERNEST  WITEBSK¥  AND  ~AMIES  1~. MOHN  151 
Rh-positive.  Therefore, we are dealing here with Rh non-secretors, two other 
examples of which were already reported in the preceding Table IV.  Case 5 
can also be readily explained on the basis of non-secretion of Rh  substance. 
In this case there was no Rh substance in the amniotic fluid though the baby 
was  Rh-positive  and  the  mother  Rh-negative.  This  particular  case  is  of 
especial interest to us because it was a clinical case of erythroblastosis and will 
be discussed later. 
The determination of the Rh factor of the baby is complicated by the fact 
that placental blood cells,  as well as red blood cells obtained from newborn 
babies,  occasionally are not  strongly agglutinated  by anti-Rh  serum.  This, 
too, parallels the experience gained with the four major blood groups.  How- 
ever,  in  the  case of the  Rh factor,  the  complications arising from the weak 
TABLE VI 
Comparison between Secretion and Non-Secretion of Rh Substames and of Blood 
Substances into A mniotic Fluid 
Group Sp~ifw 
Case No.  Rh type  Rh secretion  Blood group  Blood group  secretion 
122 
115 
6 
112 
15 
27 
97 
28 
16 
143 
106 
Rh~ 
Rh- 
Rh  + 
Rh  + 
Rh  + 
Rh  + 
Rh+ 
Rh  + 
Rh  + 
Rh  + 
Rh  + 
Negative 
Negative 
Negative 
Negative 
Positive 
Positive 
Negative 
Positive 
Negative 
Negative 
Positive 
A 
A 
A 
A 
A 
A 
B 
B 
AB 
AB 
AB 
Positive 
Negative 
Positive 
Negative 
Positive 
Negative 
Positive 
Positive 
Negative 
Positive 
Positive 
agglutinability of the newborn ceils are even more prone to give rise to mistaken 
determinations.  We had  several instances  of seemingly Rh-negative babies 
whose  amniotic  fluids  contained  Rh  substances.  In  some  of  these  cases, 
repeated  examination  of  the  baby's  ceils  revealed  small  clumps  under  the 
microscope  provided  stronger  concentrations  of  anti-Rh  serum  were  used. 
As mentioned  before  the  secretion  of  the  blood  group  specific substances 
A and B into the body fluids is a constitutional property, the gene of secretion 
being dominant over the gene of non-secretion.  The question arose whether 
the  secretion of the  Rh  substances into  amniotic fluid  was governed by the 
same gene responsible for the secretion of the blood group specific substances 
or by an entirely independent gene.  Ten amniotic fluids have been selected at 
random.  The occurrence of group specific substances and of Rh substances in 
these fluids is recorded in Table VI. 
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which  could be at variance  with  the  explanation  of a  single controlling gene; 
the strongest evidence for this assumption is case 27 in which Rh substance and 
not  the  blood group  specific substance  was  found  in  the  secretion. 
Results reported in this paper are based  upon  the examination of a  series of 
100 amniotic fluids.  Actually many more were collected but had to be excluded 
TABLE VII 
Analysis of a Series  of 100 Amniotic Fluids 
I.  Blood Groups of Newborn 
Group O ..........................................  41 
Group A ..........................................  43 
Group B  .........................  11 
Group AB .........................................  5 
II.  Blood Group Specific  Secretion into A mniotic  Fluid 
1.  Group A ........................................ 
Secretors ...................................... 
Non-secretors ................................. 
2.  Group B ........................................ 
Secretors ...................................... 
Non-secretors ................................. 
3.  Group AB ...................................... 
Secretors ...................................... 
Non-secretors ................................. 
43 
34 
9 
11 
11 
0 
79.1 per cent 
20.9per cent 
100.0 per cent 
0.0 per cent 
40.0 per cent 
60.0 per cent 
IlL  RA Types of Newborn 
Rh-positive ........................................  I  86 
Rh-negative .......................................  I  14 
IV.  Rh Secretion into Amnoitio Fluid 
1.  Rh-posifive ..................................... 
Secretors ...................................... 
Non-secretors ................................. 
2.  Rh-negative ..................................... 
86 
71 
15 
14 
82.6 per cent 
17.4 per cent 
from  our final analysis  because  of one of  the following four reasons:  (1)  The 
baby's  blood  cells were not obtained.  (2)  Occasional  amniotic fluids proved 
to  be  hemolytic--a  phenomenon  for  which  we  have  no  explanation  at  the 
present  time.  (3)  The  amniotic  fluid  was  contaminated  with  blood,  thus 
making  a  definite  diagnosis  difficult.  (4)  In  some  instances  the  diagnosis  of 
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or as far as the  occurrence of Rh substances in  the amniotic fluid  were con- 
cerned.  This  occurred  in  about  10  per cent  of  the  amniotic fluids  studied. 
However, there was no doubt in our minds as to the baby's Rh type and as 
to  the  occurrence of the Rh substances in  the amniotic fluids in  the  100  re- 
maining cases.  The analysis of these 100 cases is given in Table VII. 
The  distribution  of  the  major blood  groups  as  well  as  their  division  into 
secretors and non-secretors follows the expected percentages as recorded in the 
American white population.  The percentage distribution  of Rh-positive and 
Rh-negative bloods, too, agrees with the figures related to the American white 
population--86  per  cent  being  Rh-positive  and  14  per  cent  Rh-negative. 
Among the Rh-positive newborns a  great  majority, at least  four out  of five 
secrete  Rh  substances  into  the  amniotic  fluid.  It is  possible  that  the  per- 
centage  of non-secretors reported in  this paper,  namely 17.4 per cent might 
be reduced  somewhat further because the  content  of Rh  substances in some 
instances might have been so slight that it could not be detected by our present 
methods.  A  similar situation  is found  regarding  the  secretion  of  the  blood 
group-specific  substances.  The  occurrence  of  small  amounts  of  A  and  B 
substances makes it difficult sometimes to decide whether we are dealing with 
a  secretor  or  a  non-secretor.  Concentration  and  isolation  of  the  Rh  sub- 
stances  from the  amniotic fluid  will  materially  clarify the  problem of  weak 
secretors. 
DISCUSSION 
The Rh  subtypes of the placental  blood  cells  could  not  be determined  as 
routine.  We had to be satisfied with the diagnosis of the Rh factor as such, 
employing for that  purpose  our  Rh  anti-serum  (Kru)  which  belongs  to  the 
87 per cent variety.  However, small  amounts of anti-Rh  t and anti-Rh pp sera 
were available and were used occasionally.  The diagnosis of the subtypes of 
the Rh factor of the red blood cells of the newborn proved to be a  somewhat 
difficult  and  doubtful  procedure  in  some  cases.  It should  be mentioned  in 
this connection that the amniotic fluid of a  5 months old fetus contained Rh 
substances. 
While the determinations of the subtypes of the Rh factor of the newborn's 
cells  were  not  included  in  this  study,  the  amniotic  fluids  themselves  were 
tested against Rhl and Rh2 cells on a routine basis and frequently against Rh0 
and RhlRh2 cells also.  The occurrence of the Rh0 factor in amniotic fluid will 
have to be studied later preferably with fluids from colored patients because of 
the reported higher incidence of the Rh0 type in colored people (41.6 per cent) 
(22). 
The interest of the medical profession in the Rh factor has been aroused by 
its  relationship  to  the  pathogenesis  of  erythroblastosis.  According  to  the 
observations of Levine and his  coworkers erythroblastosis of the newborn is 
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At  the  present time it is difficult to  understand why differences in the four 
major blood groups do not constitute a  cause of  erythroblastosis.  This has 
been explained tentatively by the fact that the blood group specific substances 
occur in all tissues and organs in addition  to  the  red  blood cells while the 
Rh factor is supposedly limited to  the red blood cells. 
The investigations reported in this paper prove the occurrence of Rh sub- 
stances in amniotic fluid.  From the quantitative standpoint the amounts are 
considerably smaller than  those  of  the  A  and  B  substances also  present  in 
amniotic fluid. 
Is there any connection between erythroblastosis on the one hand and the 
state  of  secretion or  non-secretion of  the  Rh  substances into amniotic  fluid 
on the  other hand?  Such a  possibility has been mentioned previously  at  a 
time however, when there was nothing known about the presence or  absence 
of Rh factors in body fluids. 
There was one case of erythroblastosis among the  100 cases reported  here, 
namel);, case 5  (Table V), exhibiting the following features:-- 
This patient's first pregnancy resulted in a normal, living child born in August, 1943.  In 
November, 1944, being about 8½ months pregnant, she consulted a physician because she had 
felt no life for about 2 weeks.  At this time no fetal heart sounds were heard and there was 
x-ray evidence of fetal death.  About 2 weeks later she had a still-birth of a macerated, male 
fetus.  The blood cells of the fetus were Rh-positive.  The amniotic fluid did not contain any 
Rh substances, suggesting the fact that we were dealing with an Rh-positive non-secretor. 
This amniotic fluid though was contaminated with meconium.  The mother was Rh-negative 
and "blocking antibodies" of high titer were found in her serum.  There were no Rh agglu- 
tinins demonstrable by the usual test tube incubation method. 
We  had  the  opportunity  to  examine  two  more  cases  of  erythroblastosis 
in addition to the 100 cases analyzed in this paper.  Brief summaries of these 
cases  are  as follows:- 
The second case  of erythroblastosis (No.  176)  presented the following fea- 
tures :- 
In 1938 the patient bore a normal, living child.  Her second pregnancy in 1943 ended at 
term with the delivery of a living child who died 3 days after birth of unknown causes.  In 
March, 1945, the patient's third pregnancy terminated in the delivery a markedly jaundiced 
baby who showed 50 per cent nucleated red blood cells in the cord smear.  The baby died 4 
days after  birth with typical manifestations of erythroblastosis neonatorum.  The mother 
was found  to  be Rh-negative,  the baby to be Rh-positive.  "Blocking antibodies"  were 
demonstrated in the mother's serum.  The amniotic fluid, which was slightly bloody, showed 
no Rh substances to be present. 
The third case  (No.  179)  of erythroblastosis gave the following history:-- 
In 1939 the patient had a spontaneous miscarriage at 4 months.  Her second  pregnancy 
ended in October, 1943, in a  macerated  still-born baby.  When she became pregnant the 
third time her blood was examined for the  Rh factor.  The patient was found to be Rh 
negative.  Examination  of her serum revealed the presence of "blocking antibodies" in high ERNEST  WITEBSK¥  AND  ~A~-v.S ~.  MOHN  155 
fiter.  As a result  of this  information,  the obstetrician decided upon a  Caesarean section 4 
weeks before term in an attempt to save the baby's life.  The operation was performed in 
March,  1945, with the delivery of a live but icteric child.  The baby became increasingly 
jaundiced and died 4 days after birth in spite of the premature  delivery and at postmortem 
presented  typical findings of icterus  gravis  and  other  manifestations  of erythroblastosis 
neonatorum.  The baby was Rh-positive.  Examination  of the amniotic fluid obtained  at 
delivery showed that it was free from Rh substances.  This amuiotic fluid was clean and not 
contaminated  with  either  blood or meconinm. 
Our three cases of erythroblastosis came from Rh-negative mothers who had 
been delivered  of Rh-positive  children,  all  three  of whom proved to be non- 
secretors.  We are fully aware of the fact that the number of cases is insufficient 
to draw any conclusions regarding the pathogenesis of erythroblastosis.  How- 
ever,  the findings seem to be of sufficient interest  to warrant further  investi- 
gations  in  that  direction. 
It  seems  conceivable  that  difference  in  sub-types  might  also  have  to  be 
considered  in  this  connection.  For instance,  the  absence  of one part  of the 
Rh system in spite of the presence of a  different part might constitute a  suffi- 
cient reason for the  development  of erythroblastosis.  Similar  considerations 
might  also be  entertained  to explain  erythroblastosis  on the  basis  of the  Hr 
factor. 
SIYMTMARY 
1.  Rh substances are found in amniotic fluid.  Not all anti-Rh sera seem to 
be  suitable  for  the  detection  of  Rh  substances  in  amniotic  fluid.  Careful 
selection  of  Rh  antisera,  as  well  as  quantitative  considerations,  determine 
success or failure of their demonstration. 
2.  The baby's Rh type and  not the mother's determines  the occurrence of 
Rh  substances  in  amniotic  fluid. 
3.  There are Rh secretors and Rh non-secretors.  At least four out of five 
individuals  are  secretors. 
4.  The secretion of Rh substance into the amniotic fluid would seem to be 
entirely independent of the secretion of the blood group specific substances. 
5.  The  majority  of Rh-positive  amniotic  fluids  seem  to  contain  both  Rhl 
and  Rh~  substances.  However,  in  certain  instances  fluids  belonging  to  the 
pure  Rhl  type or pure  Rh~  type were found. 
6.  Three  cases  of  erythroblastosis  were  described.  All  three  came  from 
Rh-negative  mothers  with  Rh-positive  babies.  The  amniotic  fluids  of  all 
three failed to reveal the presence of Rh substances. 
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